Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests sleep pills to boost knee surgery recovery

NCT ID NCT07598734

First seen Jun 05, 2026 · Last updated Jun 23, 2026 · Updated 4 times

Summary

This study tests whether the sleep aids doxepin and ramelteon can improve sleep quality during the first 6 weeks after total knee replacement. About 129 adults will be randomly assigned to take doxepin alone, doxepin plus ramelteon, or a placebo pill each night. The goal is to see if better sleep leads to less pain, better knee function, and improved quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP QUALITY POST-TKA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Washington Medical Center Hip & Knee Center

    Seattle, Washington, 98133, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

doxepin and ramelteon

What this could lead to

If it works, this could provide a safe, effective option to improve sleep and recovery after knee replacement surgery.

What could go wrong

This is a small, early-phase trial (129 people) testing drugs for a short period. Results may not apply to everyone, and side effects or lack of benefit are possible.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.